GEN Roundup: Bioprocess Filtration Adjusts for Smooth Flows
Avoiding Downstream Production Snarls Is an Exercise in Traffic Management
The Reality of Puerto Rico after Maria
Big Pharma Provides Resilience and Hope
Top 10 Under 40
Biopharma Research and Businesses Benefit from Contributions of Emerging Leaders
Managing Biosimilars Is Like Herding Copycats
Developers and Regulators Are Attending to Naming Conventions and Equivalence Testing Assays
For full access to this article login to GEN Select now.
Stem Cell Manufacturing: It’s All about Scale
Stem Cell–Based Products Aren’t Rolling Off Assembly Lines Yet
- According to one forecast, the stem cell market will grow at an annual rate of 9.2% and attain a value of almost $16 billion by 2025. This prediction, from a 2017 study by Grand View Research, may not justify any career- or life-altering decisions—not by itself. It does correlate, ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.